Biblio

13 resultats trouvés
Filtres: Auteur is Guillemet, Cecile  [Clear All Filters]
A
Pautier P, Floquet A, Chevreau C, Penel N, Guillemet C, Delcambre C, Cupissol D, Selle F, Isambert N, Piperno-Neumann S et al..  2020.  A single-arm multicenter phase II trial of doxorubicin (Doxo) in combination with trabectedin (Trab) given as first-line treatment to patients with metastatic/advanced uterine (U-LMS) and soft tissue leiomyosarcoma (ST-LMS): Final results of the LMS-02 st. JOURNAL OF CLINICAL ONCOLOGY. 38
B
Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JOlivier, Zabotto LMoureau, Bompas E, Piperno-Neumann S, Penel N et al..  2018.  Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO). ONCOLOGIST. 23:948-955.
D
Blanc-Durand F, Lefeuvre-Plesse C, Ray-Coquard I, Chaltiel D, Floquet A, Meriaux E, Berton D, Bello-Roufai D, Guillemet C, Dupre P-F et al..  2020.  Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT). GYNECOLOGIC ONCOLOGY. 159:129-135.
E
Blanc F, Lefeuvre C, Floquet A, Chaltiel D, Ray-Coquard ILaure, Meriaux E, Berton D, Bello D, Guillemet C, Dupre P-F et al..  2020.  Effect of high-dose chemotherapy with autologous stem cell rescue (HDC-aSCR) on outcome in ovarian small-cell carcinoma, hypercalcemic type (SCCOHT): Prospective series from the French Rare Gynecologic Malignant Tumors Network (TMRG).. JOURNAL OF CLINICAL ONCOLOGY. 38
Duprez C, Vanlemmens L, Untas A, Antoine P, Lesur A, Loustalot C, Guillemet C, Leclercq M, Segura C, Carlier D et al..  2017.  Emotional distress and subjective impact of the disease in young women with breast cancer and their spouses. FUTURE ONCOLOGY. 13:2667-2680.
M
Penel N, Coindre J-M, Bonvalot S, Italiano A, Neuville A, Le Cesne A, Terrier P, Ray-Coquard I, Ranchere-Vince D, Robin Y-M et al..  2016.  Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France. EUROPEAN JOURNAL OF CANCER. 58:90-96.
P
Maillard M, Chevreau C, Le Louedec F, Cassou M, Delmas C, Gourdain L, Blay J-Y, Cupissol D, Bompas E, Italiano A et al..  2020.  Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma. CANCERS. 12:3647.
Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, Blouet A, Chaigneau L, Duffaud F, Piperno-Neumann S et al..  2014.  Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group. EUROPEAN JOURNAL OF CANCER. 50:128-136.
S
Mir O, Brodowicz T, Italiano A, Wallet J, Blay J-Y, Bertucci F, Chevreau C, Piperno-Neumann S, Bompas E, Salas S et al..  2016.  Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial. LANCET ONCOLOGY. 17:1732-1742.
T
Congard A, Christophe V, Duprez C, Baudry A-S, Antoine P, Lesur A, Loustalot C, Guillemet C, Leclercq M, Segura C et al..  2019.  The self-reported perceptions of the repercussions of the disease and its treatments on daily life for young women with breast cancer and their partners. JOURNAL OF PSYCHOSOCIAL ONCOLOGY. 37:50-68.
Vanlemmens L, Christophe V, Duprez C, Congard A, Lesur A, Loustalot C, Guillemet C, Leclercq M, Antoine P.  2014.  The subjective quality of life of young patients with breast cancer and their partners.. JOURNAL OF CLINICAL ONCOLOGY. 32
Pautier P, Floquet A, Chevreau C, Penel N, Guillemet C, Delcambre C, Cupissol D, Selle F, Isambert N, Piperno-Neumann S et al..  2015.  Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial. LANCET ONCOLOGY. 16:457-464.
Le Cesne A, Ray-Coquard I, Duffaud F, Chevreau C, Penel N, Nguyen BBui, Piperno-Neumann S, Delcambre C, Rios M, Chaigneau L et al..  2015.  Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group. EUROPEAN JOURNAL OF CANCER. 51:742-750.